Cue Biopharma(CUE)

1.65 -0.09 -5.1724%

今开:1.74昨收:1.74
最高:1.83 最低:1.65
涨停价:0.0跌停价:0.0
总市值:8.0261471E7

Cue Biopharma的热门讨论

员工持股计划

Cue Biopharma(CUE)03-29 04:35

$Cue Biopharma(CUE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-038084  Act: 33  Size: 146 KB 网页链接查看全文

持股变动声明

Cue Biopharma(CUE)03-09 05:05

$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028609  Size: 5 KB 网页链接查看全文

持股变动声明

Cue Biopharma(CUE)03-09 05:05

$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028612  Size: 5 KB 网页链接查看全文

持股变动声明

Cue Biopharma(CUE)03-09 05:05

$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028608  Size: 5 KB 网页链接查看全文

股东委托书协议

Cue Biopharma(CUE)04-27 04:05

$Cue Biopharma(CUE)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-049072  Act: 34  Size: 1 MB 网页链接查看全文

超过5%股东持股披露

Cue Biopharma(CUE)03-12 06:45

$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001781002-24-000025  Act: 34  Size: 41 KB 网页链接查看全文

年度财报

Cue Biopharma(CUE)03-29 04:45

$Cue Biopharma(CUE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038059  Act: 34  Size: 12 MB 网页链接查看全文

持股变动声明

Cue Biopharma(CUE)03-09 05:05

$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028613  Size: 5 KB 网页链接查看全文

持股变动声明

Cue Biopharma(CUE)03-09 05:05

$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028611  Size: 5 KB 网页链接查看全文

季度财报

Cue Biopharma(CUE)05-10 04:05

$Cue Biopharma(CUE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-056838  Act: 34  Size: 7 MB 网页链接查看全文

1 2

Cue Biopharma的最新讨论

Cue Biopharma的公告

其他

$Cue生物制药(CUE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-133541  Act: 34  Size: 408 KB 网页链接

股东委托书协议

$Cue生物制药(CUE)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-22-133519  Act: 34  Size: 1 MB 网页链接

持股变动声明

$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-022570  Size: 10 KB 网页链接

持股变动声明

$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-022578  Size: 8 KB 网页链接

持股变动声明

$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-022568  Size: 6 KB 网页链接

当期报告

$Cue生物制药(CUE)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001193125-22-089787  Act: 34  Size: 442 KB 网页链接

持股变动声明

$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-021502  Size: 5 KB 网页链接

持股变动声明

$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-021456  Size: 7 KB 网页链接

持股变动声明

$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-021458  Size: 7 KB 网页链接

持股变动声明

$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-021446  Size: 7 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34